Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stem cells enhance mitochondrial function in experimental Huntington's disease.

Stem cells (Dayton, Ohio)·2026
Same author

Prediction of molecular subtypes from histology: AI-driven analysis of prostate cancer morphological patterns and therapeutic implications.

NPJ precision oncology·2026
Same author

Apolipoprotein A1 reduces blood-spinal cord barrier leakage, improves astrocytic coverage, and enhances motor neuron survival to restore the neurovascular unit in ALS mice.

Frontiers in aging neuroscience·2026
Same author

Artificial Intelligence (AI)-Driven Screening of Equivocal Prostate Immunohistochemistry (IHC) Cases: Development and Validation of a Screening and Cancer Detection Framework.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025
Same author

Ischemic Penumbra Protection: Beyond Brains or Not.

MedComm·2025
Same author

Stem Cells Run Like Clockwork for Stroke Therapeutics.

Stem cell reviews and reports·2025

Related Experiment Video

Updated: Nov 3, 2025

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

10.7K

Bone marrow-derived NCS-01 cells for ischemic stroke.

Madeline Saft1, Minako Koga2, Cesario V Borlongan3

  • 1College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, MI, USA.

Brain Circulation
|June 4, 2021
PubMed
Summary
This summary is machine-generated.

Adult human bone marrow-derived NCS-01 cells show promise for stroke treatment. These stem cells improved motor function and reduced brain damage in rat models, offering a potential new therapy.

Keywords:
Filopodia formationNCS-01 cellsintracarotid arteryischemiastroke

More Related Videos

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
08:22

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Published on: June 20, 2025

231
Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
12:14

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

35.5K

Related Experiment Videos

Last Updated: Nov 3, 2025

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

10.7K
Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
08:22

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Published on: June 20, 2025

231
Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
12:14

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

35.5K

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Stroke is a leading cause of adult mortality worldwide.
  • Current treatments like tissue plasminogen activator have limitations.
  • Stem cell therapy presents a promising alternative for stroke recovery.

Purpose of the Study:

  • To evaluate the efficacy of adult human bone marrow-derived NCS-01 cells as a potential stroke treatment.
  • To investigate the therapeutic potential of NCS-01 cells in preclinical stroke models.

Main Methods:

  • NCS-01 cells were administered intracarotidly to rat stroke models at a dosage of 7.5 × 10^6 cells/ml within 3 days post-stroke.
  • Middle cerebral artery occlusion was used to induce stroke in rats.
  • Behavioral, neurological, and histological outcomes were assessed.

Main Results:

  • NCS-01 cell treatment significantly improved motor and neurological behaviors in stroke models.
  • A notable reduction in infarct area and peri-infarct cell loss was observed.
  • NCS-01 cells demonstrated superior therapeutic effects compared to other stem cell lines, potentially due to filopodia formation.

Conclusions:

  • Adult human bone marrow-derived NCS-01 cells are a safe and effective potential treatment for stroke.
  • The filopodia-mediated mechanism of NCS-01 cells contributes to their enhanced therapeutic efficacy.
  • Further research into NCS-01 stem cells is warranted for stroke treatment development.